PHS
HZNP
PFM Health Sciences’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,091,840
| Closed | -$112M | – | 87 |
|
|
2023
Q2 | $112M | Hold |
1,091,840
| – | – | 4.36% | 3 |
|
|
2023
Q1 | $119M | Hold |
1,091,840
| – | – | 5.26% | 1 |
|
|
2022
Q4 | $124M | Hold |
1,091,840
| – | – | 4.45% | 1 |
|
|
2022
Q3 | $67.6M | Hold |
1,091,840
| – | – | 2.44% | 10 |
|
|
2022
Q2 | $87.1M | Hold |
1,091,840
| – | – | 3.32% | 7 |
|
|
2022
Q1 | $115M | Hold |
1,091,840
| – | – | 4.3% | 2 |
|
|
2021
Q4 | $118M | Sell |
1,091,840
-469,450
| -30% | -$50.6M | 4.01% | 4 |
|
|
2021
Q3 | $171M | Sell |
1,561,290
-26,058
| -2% | -$2.85M | 5.03% | 1 |
|
|
2021
Q2 | $149M | Hold |
1,587,348
| – | – | 4.66% | 2 |
|
|
2021
Q1 | $146M | Buy |
1,587,348
+258,545
| +19% | +$23.8M | 4.46% | 3 |
|
|
2020
Q4 | $97.2M | Sell |
1,328,803
-30,617
| -2% | -$2.24M | 3.42% | 4 |
|
|
2020
Q3 | $106M | Buy |
1,359,420
+216,942
| +19% | +$16.9M | 4.88% | 3 |
|
|
2020
Q2 | $63.5M | Buy |
+1,142,478
| New | +$63.5M | 3.29% | 3 |
|